1. Home
  2. SXI vs OGN Comparison

SXI vs OGN Comparison

Compare SXI & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SXI
  • OGN
  • Stock Information
  • Founded
  • SXI 1955
  • OGN 1923
  • Country
  • SXI United States
  • OGN United States
  • Employees
  • SXI N/A
  • OGN N/A
  • Industry
  • SXI Industrial Machinery/Components
  • OGN Biotechnology: Pharmaceutical Preparations
  • Sector
  • SXI Industrials
  • OGN Health Care
  • Exchange
  • SXI Nasdaq
  • OGN Nasdaq
  • Market Cap
  • SXI 2.4B
  • OGN 2.7B
  • IPO Year
  • SXI N/A
  • OGN N/A
  • Fundamental
  • Price
  • SXI $208.02
  • OGN $10.70
  • Analyst Decision
  • SXI Strong Buy
  • OGN Hold
  • Analyst Count
  • SXI 4
  • OGN 4
  • Target Price
  • SXI $223.50
  • OGN $18.00
  • AVG Volume (30 Days)
  • SXI 86.0K
  • OGN 3.6M
  • Earning Date
  • SXI 10-28-2025
  • OGN 10-30-2025
  • Dividend Yield
  • SXI 0.61%
  • OGN 0.76%
  • EPS Growth
  • SXI N/A
  • OGN N/A
  • EPS
  • SXI 4.64
  • OGN 2.69
  • Revenue
  • SXI $790,107,000.00
  • OGN $6,281,000,000.00
  • Revenue This Year
  • SXI $14.61
  • OGN N/A
  • Revenue Next Year
  • SXI $7.59
  • OGN $1.36
  • P/E Ratio
  • SXI $45.23
  • OGN $3.90
  • Revenue Growth
  • SXI 9.64
  • OGN N/A
  • 52 Week Low
  • SXI $128.85
  • OGN $8.01
  • 52 Week High
  • SXI $212.66
  • OGN $20.96
  • Technical
  • Relative Strength Index (RSI)
  • SXI 57.03
  • OGN 65.42
  • Support Level
  • SXI $204.45
  • OGN $10.24
  • Resistance Level
  • SXI $211.83
  • OGN $10.95
  • Average True Range (ATR)
  • SXI 5.61
  • OGN 0.40
  • MACD
  • SXI -1.04
  • OGN 0.07
  • Stochastic Oscillator
  • SXI 74.29
  • OGN 86.89

About SXI Standex International Corporation

Standex International Corp is an industrial manufacturer of different products and services used in commercial and industrial markets. The company has five reportable segments: Electronics, Engraving, Scientific, Engineering Technologies, and Specialty Solutions. The maximum revenue is generated from its Electronics segment, which is a component and value-added services provider of both sensing and switching technologies, as well as magnetic power conversion components and assemblies, like custom wound transformers and inductors, current sense technology, value-added assemblies, and mechanical packaging, among others. Geographically, it derives key revenue from the United States and the rest from the Asia Pacific, Europe, the Middle East, and Africa (EMEA), as well as other regions.

About OGN Organon & Co.

Organon & Co is a science-based pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.

Share on Social Networks: